Published Date: 02 Mar 2023
A deep learning model called Sybil can predict future lung cancer risk based on a low-dose chest CT scan and identify people who are likely to benefit from regular treatment.
Read Full News1.
The FDA has approved momelotinib for use in myelofibrosis patients who also have anemia.
2.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
3.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
4.
As pesticides and wildfires rise, kids with cancer need resources
5.
Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer
1.
Exploring the Potential of Bendamustine in Cancer Treatment
2.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
3.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
4.
Understanding Histiocytosis: Symptoms, Causes, and Treatment Options
5.
Environmental Carcinogen Avoidance in Precision Prevention
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Role of Platelets in Normal Blood Clotting
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
3.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
How Hematologists Evaluate Persistent Blood Abnormalities
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation